Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Roarty K, Baxley SE, Crowley MR, Frost AR, Serra R
Breast Cancer Res 2009, 11:R19
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network
Huang Y, Li S
BMC Bioinformatics 2010, 11(Suppl 1):S32 (18 January 2010)
 [Abstract] [Full text] [PDF]
2.


Research    
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, Atabey N, Ozturk M
Molecular Cancer 2009, 8:90 (22 October 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.


Editorial    
Links between transforming growth factor- and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity
Incassati A, Pinderhughes A, Eelkema R, Cowin P
Breast Cancer Research 2009, 11:103 (20 May 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.